Oxford BioTherapeutics

ADC Space Continues to Thrive with Four More Companies Linking Up
BioSpace
Thu, 06/16/22 - 10:30 am
antibody-drug conjugate
Exelixis
Bioinvent
Oxford BioTherapeutics
Immunogen
Oxford BioTherapeutics to research cell therapies for Gilead’s Kite
Pharmaforum
Thu, 01/7/21 - 11:28 am
Kite Pharma
Gilead Sciences
Oxford BioTherapeutics
solid tumors
blood cancer
cell therapy